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Background: Solenostemon monostachyus P. Beauv (family Lamiaceae), a medicinal herb in West and Central Africa, is 
ethnomedically employed as an antidote for poison and for the treatment of different diseases and ailments.  
Objective: To investigate the hepatoprotective and renoprotective effects of S.  monostachyus leaf extract against 
paracetamol- induced liver and kidney injuries in rats.  
Methodology: Hepato-renoprotective effects of S. monostachyus ethanol leaf extract was evaluated against 
paracetamol- induced liver and kidney injuries in rats. The liver protective property of the ethanol leaf extract (75-
225 mg/kg) was investigated by the assessment of liver function parameters, liver antioxidant enzymes and 
histopathology, while the renoprotective property was evaluated by the assessment of some kidney function 
parameters, kidney antioxidant enzymes and histopathology. Silymarin (100mg/kg) was used as positive control. 
Results : The leaf extract exerted significant (p<0.05 – 0.001) dose-dependent decreases in elevated levels of liver 
enzymes (ALT, AST and ALP), total cholesterol, direct and total bilirubin as well as increases in serum levels of total 
protein, albumin and antioxidant enzymes (SOD, CAT, GPx) and GSH. Histopathological study of the liver sections of 
extract and silymarin-treated rats revealed reductions in the pathological features compared to the paracetamol- 
treated animals. Leaf extract pre-treatment also resulted in significant (p<0.05) dose-dependent decreases in 
increased levels of serum creatinine and urea without affecting the electrolytes levels. Histopathology of the kidney 
sections of extract and silymarin- treated rats showed decreases in the pathological features compared to the control 
group. The chemical pathological results in both liver and kidney agreed with histopathological observations 
indicating pronouced hepatoprotective and renoprotective effect of the leaf extract of S. monostachyus.  
Conclusion: The results of this study demonstrate that the leaf extract of S. monostachyus has the potentials to protect 
the liver and kidney against injury which may be due to its antioxidant activity of its constituents and this can be 
employed in the management of liver and kidney diseases. 
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1. Introduction 
Solenostemon monostachyus P. Beauv (family 
Lamiaceae) is an herb widely distributed in West and 
Central Africa. It is a succulent annual weed 
predominant in anthropogenic habitats and rocky 
savannahs and grows up to 100 cm tall (Mve-Mba et al, 
1994).  The aerial parts are employed ethnomedically 
by the Ibibios of the Niger Delta of Nigeria to treat 
stomach ulcer, fever/malaria (Ajibesin et al, 2008; 
Adebayo and Krettli, 2011), and other diseases. The 
plant is used as a diuretic as well as to treat 
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hypertension (Koffi et al, 2009). The plant has been 
found to contain essential oil (Mve-Mba et al, 1994), 
diterpenoids (Toshio et al, 1980), flavonoids, coumarin 
and polyphenol (Datte et al, 2010; N’guessan et al, 
2011).  The essential oil contains; β-pinene, oct-1-en-3-
ol, β-caryophyllene, octan-3-ol and (E,E)-α-farnesene 
(Mvé-Mba  et al, 1994). Previous works on the plant 
include; antioxidant (Datte et al, 2010; N’guessan et al, 
2011; Okoko and Ere, 2012), antihypertensive (Fidele et 
al, 2012) and antimicrobial activities (Ekundayo and 
Ezeogu, 2006), antipyretic and antiplasmodial (Okokon 
et al, 2016a), analgesic and anti-inflammatory (Okokon 
et al, 2016b). This investigation was carried to evaluate 
the hepatoprotective and nephroprotective effect of 
Solenostemon monostachyus and support its use in 
traditional medicine to treat liver and kidney disorders. 
2. Materials and Methods 
2.1 Plant collection 
The plant material, (S. monostachyus aerial parts) were 
collected in a farm area in Uyo, Akwa Ibom State, 
Nigeria in August, 2014. The plant was identified and 
authenticated by a taxonomist in Department of Botany 
and Ecological Studies, University of Uyo, Uyo, Nigeria. 
Hebarium specimen (FPUU 573) was deposited at 
Department of Pharmacognosy and Natural Medicine 
Herbarium. 
2.2 Extraction 
The aerial parts were washed, shade-dried for 2 weeks 
and further reduced to powder using electric grinder. 
The powdered material was macerated in ethanol 
(50%) for 72 h. The liquid filtrate was concentrated and 
evaporated to dryness in vacuo 40C using rotary 
evaporator. The liquid filtrate was concentrated and 
evaporated to dryness in vacuo 40C using rotary 
evaporator. The dry extract was stored in a refrigerator 
at - 4C until use for the proposal experiment  
2.3 Phytochemical Screening 
Phytochemical screening of the crude extract was done 
using standard procedures and tests (Trease and Evans, 
1989; Sofowora, 1993),  
2.4 Animals 
Albino rats (110 – 150 g) of both sexes were gotten 
from the University of Uyo animal house. They were 
maintained on standard animal pellets and water ad 
libitum. Permission and approval for animal studies 
were obtained from the College of Health Sciences 
Animal Ethics committee, University of Uyo. 
2.5 Determination of median lethal dose (LD50) 
The median lethal dose (LD50) of the extract was 
determined in albino mice using intraperitoneal (i.p) 
route employing the method of Lorke (1983). This 
involved intraperitoneal treatment groups of three mice 
each with different doses of the extract (100 -1000 
mg/kg). The animals were observed for manifestation 
toxicity signs such as writhing, decreased motor 
activity, decreased body/limb tone, decreased 
respiration and death. The number of deaths in each 
group within 24 hours was recorded. The LD50 was 
calculated as geometrical means of the maximum dose 
producing 0% and the minimum dose producing 100% 
mortality. 
2.6 Animal treatment 
Thirty-six (36) rats (male and female) were weighed 
and randomised into six groups of 6 rats each and 
treated as follows: Groups 1 animals were given only 
distilled water (0.2 ml/kg) and these were normal 
animals. Group 2 was pretreated with distilled water 
0.2 ml/kg. Groups 3, 4 and 5 were respectively 
pretreated orally with 75, 150 and 225 mg/kg of S. 
monostachyus leaf extract daily for 8 days. Group 6 was 
pretreated with silymarin (100 mg/kg) (standard drug) 
for the same period of time. On the 8th day, Paracetamol, 
2 g/kg, was administered to groups 2- 6.  
Twenty-four hours post paracetamol administration, 
the animals were sacrificed under light diethyl ether 
vapour. Blood samples were collected by cardiac 
puncture and used immediately. 
2.7 Hematological study 
Animals were sacrificed under diethyl ether anesthesia 
and blood samples were collected from each rat by 
cardiac puncture into ethylene diamine tetra-acetic acid 
(EDTA) – coated sample bottles for analysis.  
Hematological parameters which included red blood 
count (RBC), hemoglobin, (Hb), packed cell volume 
(PCV), platelet concentration (PLC) and total and 
differential white blood cell count (WBC) were 
determined. These were done using automatic 
hematological system (Sysmex Hematology – 
Coagulation system, Model MO-1000 I, Trans Asia, 
Japan).  
2.8 Biochemical and histological evaluation of the 
hepatoprotective effect of the leaf extract in rats 
with paracetamol-induced Liver injury 
 Serum gotten from the blood of each rat sacrificed was 
stored at -20 °C until used for biochemical 
determinations such as total protein, albumin, aspartate 
aminotransferases (AST), alanine aminotransferase 
(ALT), alkaline phosphatase (ALP), total cholesterol, 
total and conjugated bilirubin. The determinations were 
carried out using Randox analytical kits according to 
standard procedures of manufacturer’s protocols 
(Reitman and Frankel, 1957).  
The livers of the animals were removed, weighed and a 
portion of each fixed in 10% formaldehyde for 
histological processes, while the other part was washed 
with ice cold 0.9% NaCl and homogenates were made in 
a ratio of 1 g of wet tissue to 9 ml of 1.25% KCl by using 
motor driven Teflon-pestle. The homogenates were 
centrifuged at 7000 rpm for 10 min at 4 °C and the 
supernatants were used for the assays of superoxide 
dismutase (SOD) (Marklund et al,1974),  catalase (CAT) 
(Sinha,1972), glutathione peroxidase (GPX) (Lawrence 
and Burk,1976), and reduced glutathione (GSH) 
(Ellman,1959).  
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2.9 Biochemical and histological evaluation of the 
renoprotective effect of the leaf extract in rats with 
paracetamol-induced liver injury  
The sera samples collected from the treated- rats were 
analyzed according to standard methods for effect of 
the extract on various Determination of kidney function 
parameters such as urea and creatinine as well as some 
ions like sodium, potassium and chloride were carried 
out in the sera of the treated rats. These analyses were 
done at Department of Chemical Pathology, University 
of Uyo Teaching Hospital, (UUTH), Uyo using various 
diagnostic kits. The kidneys surgically removed from 
the rats were weighed and a portion of each fixed in 
10% formaldehyde, processed, sectioned and stained 
with Heamatoxylin and eosin (H&E) according to 
standard procedures at Department of Chemical 
Pathology, University of Uyo Teaching Hospital, Uyo. 
The other part of each kidney removed was dissected 
free from the surrounding fat and connective tissue. 
Each kidney was longitudinally sectioned, and renal 
cortex was separated and kept at −8◦C. Subsequently, 
renal cortex was homogenized in cold potassium 
phosphate buffer (0.05 M, pH 7.4). The renal cortical 
homogenates were centrifuged at 5000rpm for 10 min 
at 4 °C. The resulting supernatant was used for the 
determination of - malondialdehyde (MDA) content 
(Wilbur et al, 1949; Esterbauer and Cheeseman, 1990), 
reduced glutathione (GSH) levels and antioxidant 
enzyme levels such as superoxide dismutase (SOD), and 
catalase (CAT) activities using colorimetric assay. 
2.10 Statistical analysis and data evaluation 
Data obtained from this work were analyzed 
statistically using ANOVA (One - way) followed by a 
post test (Tukey-Kramer multiple comparison test). 
Differences between means were considered significant 
at 5% level of significance i.e. p ≤ 0.05. 
3. Results  
Alkaloids, cardiac glycosides, tannins, saponins, 
terpenes and flavonoids were found to be present in the 
ethanol extract of the aerial parts of Solenostemon 
monostachyus   
The median lethal dose (LD50) was determined to be 
748.331 mg/kg and excitation, paw licking, increased 
respiratory rate, decreased motor activity, gasping and 
coma were observed before death of the animals. 
Effect of leaf extract on haematological parameters 
of rats 
Treatment of rats with paracetamol (2 g/kg) did not 
cause any significant effect (p>0.05) on RBC, WBC PCV, 
and Hemoglobin concentration when compared to 
normal control. Administration of paracetamol to rats 
caused significant (p<0.001) reductions in percentages 
of neutrophils (15.750.13%) and monocytes 
(1.500.18%) when compared to normal control (Table 
1). However, pre-treatment of rats with S. monostachyus 
leaf extract (75 -225 mg/kg) was found to significantly 
(p<0.001) increased neutrophils and monocytes 
percentages to 37.01.30 and 7.250.20 respectively 
when compared to the untreated group. Also, the 
significantly (p<0.05 – 0.001) increased lymphocytes 
percentage (92.752.83) due to paracetamol 
administration was significantly reduced in the extract 
and silymarin – treated rats to 58.605.35% and 
63.507.08% respectively (p<0.01).  
The increase in platelet counts induced by paracetamol 
(833.017.51) was not significant (p>0.05) when 
compared to control (736.255.70). However, the 
extract administration produced a significant (p<0.01) 
increase in platelet count (935.256.29) when 
compared to the control. Silymarin did not affect 
platelet count significantly (p>0.05) when compared to 
control.  
The percentages of eosinophils and basophils were not 
affected by paracetamol administration but higher 
doses of the extract (150 and 225 mg/kg) were found to 
significantly (0.05 -0.001) increase the percentages of 
eosinophil to 2.751.10 and 2.331.15 respectively 
when compared to control (Table1). 
Effect of leaf extract on liver and kidney weights 
The liver and kidney weights of paracetamol-treated 
rats were significantly (p<0.001) increased when 
compared to that of the control group. However, pre-
treatment with the leaf extract and silymarin was found 
to significantly (p<0.01 – 0.001) reduced the weights of 
these organs (Table 2). 
Effect of leaf extract on liver function parameters in 
rats with paracetamol-induced Liver injury 
Administration of paracetamol (2 g/kg) to rats was 
found to cause significant (p<0.001) increases in liver 
enzymes levels; AST, ALT and ALP. 171.25± 1.23, 
72.62±5.52, and 155.0±4.52 IU/L were respectively 
recorded for AST, ALT and ALP when compared to 
control. Total cholesterol, total and conjugated bilirubin 
were also elevated to 3.42±0.11 mMol/L, 16.0±0.50 and 
9.48±0.52 mg/dl respectively. Decreases in total protein 
(3.60.0±0.14 g/dl) and albumin (2.01±0.16 g/dl) levels 
were also observed with paracetamol.  
The middle dose (150 mg/kg) of the extract was 
observed to cause significant (p<0.01-0.001) decreases 
in the levels of ALT and AST to 135.2± 3.20 and 
37.24±3.44 IU/L respectively when compared to the 
untreated group. Silymarin was also observed to caused 
significant (p<0.01-0.001) decreases in the levels of ALT 
and AST to 135.5±6.80  and 35.54±9.60 IU/L 
respectively when compared to the untreated group.  
The low and highest doses of the extract (75 and 225 
mg/kg) could not reverse the elevated ALT and AST 
levels caused by paracetamol. Pretreatment of rats with 
leaf extract of S. monostachyus (75–225 mg/kg) caused 
a dose-dependent significant (p<0.01-0.001) decreases 
in the levels of ALP, total cholesterol, total and 
conjugated bilirubin when compared with the 
paracetamol group. Total protein and albumin levels 
were significantly (p<0.05-0.001) increased dose-
dependently in the groups pre-treated with the leaf 
extract when compared to the paracetamol group 
(Table 3). 
 Table 1: Effect of treatment with ethanol extract of Solenostemon monostachyus on the haematological parameters of rats with paracetamol-induced hepato-nephrotoxicity. 
Treatment  
Dose (mg/kg) 
RBC 
(X 1012/l) 
PCV 
(%) 
Hb 
(g/dl) 
WBC 
(X 109/l) 
Neutrophils 
(%) 
Lymphocytes 
(%) 
Monocytes 
(%) 
Eosinophils 
(%) 
Basophils 
(%) 
Platelet 
Normal control 6.920.43 47.31.33 9.980.45 7.541.14 29.801.62 70.703.88 2.500.12 0.750.01 0.750.20 736.255.70 
PCM +Dist. water 6.920.53 50.571.49 8.070.09 9.922.58 15.750.13b 92.752.83a 1.500.18 c  0.000.00  0.500.01 833.017.51 
SM. 75mg/kg + 
PCM 
7.350.30 47.51.34 13.900.48 12.621.19 37.01.30f  58.605.38 f 3.000.14 f  1.000.55 0.500.01  820.710.33  
SM. 150mg/kg+ 
PCM 
6.950.17 49.10.70 12.510.25 13.121.07 25.02.88  65.823.80 e 4.660.10c,f 2.331.15c,f 0.000.00  935.256.29a 
SM 225mg/kg + 
PCM 
7.371.40 50.60.65 13.380.40 12.381.88 24.03.18  65.974.60e 7.250.20c,f 2.751.10c,f 0.500.01  930.236.29a 
Silymarin 
100mg/kg        + 
PCM 
7.140.60 51.463.70 11.160.50 11.502.22 41.02.49a,f 63.507.08e 4.200.12c.f 0.800.11 1.000.11  871.864.56  
Data were expressed as mean  SEM. Significant at a p< 0.05, b p< 0.01, c p< 0.001 when compared to control. d p< 0.05, e p< 0.01, f p< 0.001 when compared to paracetamol . n = 6. 
 
Table 3: Effect of Solenostemon monostachyus on liver function of PCM –induced liver injury in rats 
Parameters/ 
Treatment 
Total 
protein 
(g/dl) 
Albumin 
(g/dl) 
Total 
bilirubin 
(mg/dl) 
Conjugated 
bilirubin 
(mg/dl) 
AST 
(IU/L) 
ALT 
(IU/L) 
ALP 
(IU/L) 
Total 
cholesterol 
(Mmol/L) 
Liver weight 
(g) 
Normal control 4.58± 0.16 2.82±0.12 12.2±0.50 5.78±0.58 123.2±1.88 37.20±1.88 105.2±4.32 2.28± 0.22 7.75±1.11 
PCM +Dist. water 3.60±0.14c 2.01±0.16c 16.0±0.50c 9.48±0.52c 171.25± 1.23c 72.62±5.52c 155.0±4.52c 3.42±0.11c 9.37±0.53c 
SM. 75mg/kg + PCM 4.52±0.12e 2.90±0.18d 15.0± 0.34a 8.22±0.44b 156.25±9.81b 53.75±9.98 118.6±6.13f 2.25±0.08f 8.18±0.13f 
SM. 150mg/kg+ 
PCM 
4.48±0.15e 2.90±0.12e 12.5±0.94e 6.10±0.77e 135.2± 3.20f 37.24±3.44e 113.7±4.52f 2.34±0.11f 8.11±0.20f 
SM.225mg/kg+ PCM 4.25±0.20e 2.68±0.15f 13.0±0.27 a 8.42±0.39b 164.75±4.83c 68.23±2.38a 123.7±3.45e 2.60±0.04f 8.03±0.16f 
Silymarin 100mg/kg        
+ PCM 
4.62±0.15f 2.90±0.13f 12.5±0.64 e 6.46±0.23e 135.5±6.80f 35.54±9.60f 98.75±8.67f 2.10±0.04f 7.89±0.18f 
Data were expressed as mean  SEM. Significant at ap< 0.05, bp< 0.01, cp< 0.001 when compared to control.dp< 0.05, ep< 0.01, f< 0.001 when compared to paracetamol . n = 6. 
 Table 2:   Effect of Solenostemon monostachyus extract on Liver and Kidney weights  in paracetamol-induced kidney 
injury in rats. 
Treatment Kidney weight  (g) Liver weight  (g) 
Normal control 0.72±0.01 7.75±1.11 
PCM +Dist. Water 1.21±0.06c 9.37±0.53c 
SM. 75mg/kg + PCM 0.66±0.02f 8.18±0.13f 
SM. 150mg/kg+ PCM 0.70±0.03f 8.11±0.20f 
SM.225mg/kg+ PCM 0.67±0.02f 7.99±0.16f 
Silymarin 100mg/kg + PCM 0.72±0.03f 7.89±0.18f 
Data were expressed as mean  SEM. Significant at a p< 0.05, b p< 0.01, c p< 0.001 when compared to control. d p< 0.05, e p< 0.01, f 
p< 0.001 when compared to paracetamol . n = 6. 
Effect of the extract on kidney function parameters 
in rats with paracetamol-induced kidney injury 
Treatment of rats with paracetamol (2 g/kg) was 
observed to caused significant (p<0.001) increases in 
serum urea and creatinine levels to 8.48±0.35mMol/L 
and 168.4 ±3.12 mMol/L respectively when compared 
to control. Pre-treatment of the rats with leaf extract of 
S. monostachyus (75 – 225 mg/kg) significantly (p<0.01) 
reduced the elevated levels of serum urea and 
creatinine in a dose-dependent fashion to 5.44±0.38 
mMol/L and 109.8±13.58 mMol/L respectively when 
compared to the untreated group.  Silymarin also 
caused significant (p<0.01) reduction in serum urea and 
creatinine levels to 7.36±1.68 mMol/L and 
102.75±12.33 mMol/L respectively when compared to 
control. However, electrolytes (K+, Na+, Cl- and HCO-3) 
levels of rats were not affected by paracetamol 
administration as well as pre-treatment with the extract 
(Table 4). 
Effect of leaf extract on liver and kidney antioxidant 
enzymes  
Antioxidant enzymes and indices such as SOD, catalase, 
GPx and GSH level in liver tissue were observed to be 
significantly (p<0.001) reduced by paracetamol 
treatment to 9.87±0.30, 27.85± 0.96, 12.23±0.45, and 
0.12±0.01 U/mg of protein respectively when compared 
with control group. These reductions were  reversed by 
pre-treatment with leaf extract of S. monostachyus (75-
225 mg/kg) which resulted in a significant (p<0.05 – 
0.001) increase in the activities of SOD, catalase, GPx 
and GSH level to 16.16± 0.18, 46.38±2.19, 21.39±0.18 
and 0.27±0.02 U/mg of protein respectively at the 
highest dose of the extract (225 mg/kg). Similar 
increases were observed in silymarin-treated rats with 
values of 19.02±0.15, 50.47± 1.92, 22.11±0.81 and 
0.31±0.01 U/mg of protein respectively for SOD, 
catalase, GPx and GSH (Table 5). 
Administration of paracetamol to rats caused significant 
reduction in levels of  SOD, catalase and GSH with values 
of  7.25 ± 0.21, 22.56± 2.10 and 0.10±0.01 U/mg of 
protein respectively when compared to control 
(p<0.001). Pre-treatment with leaf extract of S. 
monostachyus (75–225 mg/kg) resulted in significant 
(p<0.05–0.001) increases in the activities of SOD, 
catalase and GSH levels in kidney tissue with values of   
17.44± 0.25, 34.22±1.06 and 0.22±0.01U/mg of protein 
respectively. Concentration of MDA which was 
significantly (p<0.001) elevated to 72.29±2.98 U/mg of 
protein in kidney tissue by paracetamol treatment was 
also reduced significantly (p<0.001) by extract 
pretreatment to 53.97±2.18 U/mg of protein. Silymarin 
treated animals also showed significant (p<0.001) 
increases in antioxidant enzymes with values of 19.70 
±0.11, 38.02± 2.16 and 0.30±0.01U/mg of protein for 
SOD, catalase and GSH respectively and  decrease in the 
level of MDA (48.56±1.86 U/mg of protein) compared to 
paracetamol treated rats (Table 6). 
 
Table 4: Effect of ethanol extract of Solenostemon monostachyus on some kidney function parameters of rat 
Parameters/ 
Treatment 
Na+ 
(mmol/l) 
K+ 
(mmol/l) 
CL- 
(mmol/l) 
HCO-3 
(mmol/l) 
UREA 
(mmol/l) 
Creatinine 
(mmol/l) 
Kidney 
weight (g) 
Normal control 140.4±0.40 9.56±0.39 102.6±0.92 27.6±0.50 5.72±0.72 106.2±3.12 0.72±0.01 
PCM +Dist. Water 143.0±0.83 8.72±0.33 102.6±0.66 28.8±0.73 8.48±0.35c 168.4 ±3.12c 1.21±0.06c 
SM. 75mg/kg + 
PCM 
142.70.94 8.120.12 102.71.70 28.25±0.85 6.86±0.70c,f 133.2±9.51a,d 0.66±0.02f 
SM. 150mg/kg+ 
PCM 
142.6  0.92 9.060.82 104.4±0.67 28.00± 0.66 5.82±0.62f 107.4±2.33f 0.70±0.03f 
SM.225mg/kg+ 
PCM 
132.8  6.71 8.520.34 104.1±2.11 26.80± 0.86 5.44±0.38f 109.8±13.58f 0.67±0.02f 
Silymarin 
100mg/ kg + PCM 
139.2±1.10 8.32±0.76 101.8±0.20 27.25± 0.25 7.36±1.68c,e 102.75±12.33f 0.72±0.03f 
Data were expressed as mean  SEM. significant at a p< 0.05, b p< 0.01, c p< 0.001 when compared to control. d p< 0.05, e p< 0.01, f 
p< 0.001 when compared to paracetamol . n = 6. 
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Table 5: Effect of Solenostemon monostachyus leaf extract on liver antioxidant enzymes 
Treatment 
SOD 
(U/mg of protein) 
CAT 
(U/mg of protein) 
GPx 
(U/mg of protein) 
GSH 
(µg/mg of protein) 
Normal control 20.14 ±0.22 58.34±1.14 23.27±0.48 0.35±0.01 
PCM +Dist. Water 9.87±0.30c 27.85± 0.96c 12.23±0.45c 0.12±0.01c 
SM. 75mg/kg + PCM 12.38±0.11c,f 33.32±0.99c 17.99±0.88c,f 0.14±0.01c 
SM 150mg/kg+ PCM 15.17±0.14 c,f 39.16±1.12 c,f 19.73 ±0.46c,f 0.24±0.01bf 
SM. 225mg/kg+ PCM 16.16± 0.18 c,f 46.38±2.19 c,f 21.39±0.18f 0.27±0.02f 
Silymarin 100 mg/kg + PCM 19.02±0.15 b,f 50.47± 1.92 b,f 22.11±0.81f 0.31±0.01f 
Data were expressed as mean  SEM. significant at a p< 0.05, b p< 0.01, c p< 0.001 when compared to control. d p< 0.05, e p< 0.01, f 
p< 0.001 when compared to paracetamol . n = 6. 
 
Table 6: Effect of Solenostemon monostachyus leaf extract on kidney antioxidant enzymes in paracetamol-induced 
kidney injury in rats. 
Parameters/ Treatment 
SOD 
(U/mg of protein) 
CAT 
(U/mg of protein) 
MDA 
(U/mg of protein) 
GSH 
(µg/mg of protein) 
Normal control 20.10 ± 0.16 45.27±0.48 40.04±1.28 0.38±0.01 
PCM +Dist. Water 7.25 ± 0.21c 22.56± 2.10c 72.29±2.98c 0.10±0.01c 
SM. 75mg/kg + PCM 10.27 ± 0.36cd 25.48±0.17c 64.28±1.20c 0.15±0.01cd 
SM 150mg/kg+ PCM 15.42 ± 0.20cf 32.56±2.02bf 56.42±1.46cf 0.20±0.01cf 
SM. 225mg/kg+ PCM 17.44± 0.25cf 34.22±1.06cf 53.97±2.18cf 0.22±0.01cf 
Silymarin 100 mg/kg + PCM 19.70 ±0.11f 38.02± 2.16af 48.56±1.86af 0.30±0.01af 
Data were expressed as mean  SEM. significant at a p< 0.05, b p< 0.01, c p< 0.001 when compared to control. d p< 0.05, e p< 0.01, f 
p< 0.001 when compared to paracetamol . n = 6. 
Effect of leaf extract on liver histology in rats with 
paracetamol-induced liver injury 
Histopathological examination of liver sections of 
control group revealed normal cellular architecture 
with distinct hepatic cells, sinusoidal spaces and central 
vein (Figure 1A). Toxicant (paracetamol) group 
demonstrated severly distorted architecture, widened 
spaces between plates of hepatocytes which contain 
haemorrhage, moderate portal inflammation, moderate 
congested sinusoid and focal necrosis (Figure 1B) . The 
liver sections of the rats treated with leaf extract of S. 
monostachyus (75 - 150 mg/kg) demonstrated signs of 
protection as was evident by mild inflammation, 
reduction of vascular congestion and degeneration, 
cellular degeneration, necrosis and vacuoles (Figure 1D 
and 1E), while the liver sections of the pretreated rats 
with S. monostachyus (225 mg/kg) were observed to 
show little or no protection with mild portal 
inflammation, moderate congested central 
veins/sinusoids and severe necrosis (Figure 1F). 
Silymarin (100 mg/kg) treated rats showed significant 
protection and absence of necrosis and inflammation 
(Figure 1C). 
Effect of leaf extract on the kidney histology in rats 
with paracetamol-induced kidney injury 
The histological pattern of normal kidney showed 
preserved architecture with normal glomeruli normal 
tubules and normal interstitial and Bowman’s capsule 
(Figure 2A). Treatments with paracetamol showed 
severely distorted architecture with moderately 
damaged glomeruli and tubules, congested to 
thrombosed interstitial blood vessels with 
inflammation, interfollicullar stroma containing severe 
congested blood vessels and areas of haemorrhage 
(Figure 2B). The rats treated with leaf extract of S. 
monostachyus (75-225 mg/kg) showed preserved 
architecture with normal glomeruli, normal tubules, 
slight inflammation and congested to thrombosed 
interstitial blood vessels (Figure 2D- 2F). Rats treated 
with silymarin showed preserved architecture with 
normal glomeruli, normal tubules and congested 
interstitial blood vessels (Figure 2C) 
4.0 Discussion 
In this study, the ethanol leaf extract of S. monostachyus 
was evaluated for hepatoprotective and renoprotective 
activities against paracetamol-induced hepato-
nephrotoxicity in rats. Liver and kidney function tests, 
liver and kidney antioxidant enzymes levels and 
histological studies were used to assess 
hepatoprotective and renoprotective properties. The 
results of this study indicated that paracetamol 
administration caused liver and kidney toxicities as 
observed in alteration of various liver and kidney 
parameters such as elevations of liver enzymes, urea 
and creatinine levels as well as other parameters. 
Paracetamol was found to cause various degrees of 
injuries to the organs. Considerable decreases in tissue 
GSH level with reduction in activities of liver 
antioxidative enzymes such as SOD and CAT and 
elevation of MDA level were equally observed.     
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Figure 1. Photomicrographs of livers of rats treated with distilled water (A), Paracetamol 2g/kg (B), Sylimarin (C), S. 
monostachyus (75mg/kg) (D), S. monostachyus (150mg/kg) (E), S. monostachyus (225mg/kg) (F). Normal hepatocytes 
(NHC), focal necrosis (FN), congested portal tract with inflammation (CPTI), congested interstitial blood vessels 
(CIBV) H & E Magnification X 10. 
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Figure 2. Photomicrographs of  kidneys of rats treated with distilled water (A), Paracetamol 2g/kg (B), Sylimarin (C), 
S. monostachyus (75mg/kg) (D), S. monostachyus (150 mg/kg) (E), S. monostachyus (225mg/kg) (F). Normal glomeruli 
(NG), normal tubules (NT), Inflammation (II), Normal interstitial (NI), Congested interstitial blood vessels (CIBV) H & 
E Magnification X 10. 
 
Paracetamol is often used in the treatment of fever and 
pains. Unfortunately, it produces acute toxic effect at 
high doses which leads to liver damage. The drug is 
metabolised to a toxic electrophile, N-acetyl p-
benzoquinone imine (NAPQI), which affect tissue 
components and alters the homeostasis of calcium (Lin 
et al, 1997). This further generate reactive species 
which leads to depletion of protective physiological 
moieties (glutathione and α-tocopherol, etc.), causing 
injuries to the macromolecules in vital biomembranes 
(Aldridge, 1981; Gilani et al, 2005).  
Liver function parameters such as serum ALT, AST, ALP, 
bilirubin (total and direct), total cholesterol, total 
protein and albumin are used to establish liver 
dysfunction (Manokaran et al, 2008). During 
hepatopathy, liver enzymes and molecules leak into the 
blood stream which indicates liver damage (Nkosi et al, 
2005). The elevated levels of serum ALT, AST, ALP, total 
bilirubin (total and direct), and total cholesterol as well 
as reductions in levels of  total protein and albumin as 
observed in paracetamol group in our study  suggest  
injury to hepatic cells and liver damage due to 
paracetamol. The extracts’ ability to reverse the 
elevated serum enzymes levels induced by paracetamol 
indicates protective potentials maybe by preventing the 
effect of the free radicals generated by paracetamol on 
liver tissue through antioxidant activities of its 
components. Synthetic ability of the liver was found to 
be compromised following paracetamol treatment as 
serum levels of total protein and albumin were 
observed to be reduced. This is likely to result from 
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reduction in the number of hepatocytes and further 
revealed the severity of hepatopathy. These reductions 
in total protein and albumin levels were reversed by 
extract pretreatment, indicating hepatoprotective 
activity by the extract. 
In this study, bilirubin level elevated by paracetamol 
was found to be significantly reduced by extract 
ptretreatment. Estimation of serum bilirubin is a useful 
index to assess hepatic function, and any abnormal 
increase in the levels of serum bilirubin indicates 
hepatobiliary disease and severe disturbance of 
hepatocellular function (Martin and Friedman, 1992). 
Reduction in serum bilirubin level following extract 
pretreatment further suggest the protective potential of 
the extract. 
Paracetamol-induced toxicity in rats is likely affects 
membrane structure and function as well as lipids 
metabolism in the liver as suggested by the increased 
cholesterol levels of rats. This effect was reduced by the 
protective activity of the leaf extract which reduced the 
increased level of total cholesterol. 
SOD and CAT are important enzymes in the enzymatic 
antioxidant defense system (Curtis et al, 1972) and 
decreases in their activities may lead to a number of 
injurious effects.  Pre-treatment with S. monostachyus 
leaf extract was observed to significantly (p < 0.05) 
increased hepatic SOD and CAT activities compared to 
control paracetamol treated group. This suggest that S. 
monostachyus possess the ability to scavenge reactive 
free radicals, thereby reducing their effects on the 
tissues in addition to improving activity of hepatic 
antioxidant system. This is further support by the 
observation that pretreatment with S. monostachyus leaf 
extract significantly increased the level of GPx and GSH 
in a dose dependent manner strongly portraying its 
ability to scavenge these free radicals.  
Haematological parameters such as RBC, Hb, PCV, WBC 
and basophil and eosinophil percentages were not affect 
by paracetamol treatment in this study, except 
reductions in the percentages of neutrophils and 
monocytes of paracetamol-treated rats. Pretreatment 
with S. monostachyus leaf extract caused significant 
(p<0.05 -0.001) increases against reductions induced by 
paracetamol and considerable reduction of lymphocytes 
though in a non-dose dependent fashion. 
 The histological findings corroborate that of the 
biochemical results laying credence to the 
hepatoprotective potentials of the extract and validating 
its use as antidote. 
Kidneys are responsible for the excretion of xenobiotics, 
pollutants, toxins and are exposed to high quantities of 
free radicals which contribute to high oxidative stress. 
This contributes majorly to the pathogenesis of kidney 
damage. The ethanol leaf extract of S. monostachyus was 
also evaluated for nephroprotective activity against 
paracetamol-induced nephrotoxicity in rats. p-amino 
phenol(PAP), a metabolite of paracetamol is implicated 
in the pathogenesis of paracetamol induced renal 
damage (Carpenter and Mudge, 1981; Mugford and 
Tarlolf, 1997).   Kidney function parameters such as 
blood urea, serum creatinine, electrolytes and tissue 
GSH levels, tissue SOD and CAT activities and MDA level 
were used to assess nephroprotective activity. 
Significant decrease in tissue level of GSH level with 
increased MDA level a product of lipid peroxidation 
were observed in this study following paracetamol 
treatment. Kidney antioxidative enzymes like SOD and 
CAT activities were also reduced. Serum urea and 
creatinine level were also observed to be elevated and 
varying degrees of histological lesions were observed as 
well. Pretreatment of the animals with leaf extract of S. 
monostachyus was found to reverse these effects on the 
kidney suggesting nephroprotective potentials of the 
extract. 
The nephro protective property of the extract is further 
confirmed by significant improvement of the kidney 
architecture by reversing the glomerular congestion, 
interstium with inflammatory cells, tubular necrosis, 
peritubular necrosis and basement degeneration over 
paracetamol administered group. 
The leaf extract and fractions have been reported to 
exhibit strong antioxidant (Datte et al, 2010; N’guessan 
et al, 2011; Okoko and Ere, 2012) activity. The leaf 
essential oil of S. monostachyus has been reported to 
contain; β-pinene, oct-1-en-3-ol, β-caryophyllene, octan-
3-ol and (E,E)-α-farnesene (Mvé-Mba  et al, 1994) and 
flavonoids, coumarin and  polyphenol (Datte et al, 2010; 
N’guessan et al, 2011) have also been isolated from the 
leaf of the plant. These compounds are potential 
antioxidant compounds and could possibly account for 
the hepatoprotective and nephroprotective properties 
of this plant. The strong antioxidant activity of this 
extract and constituents explains the significant 
hepatoprotective and nephroprotective activities of the 
leaf extract and may as well explain the mechanism of 
action of the observed hepatoprotective and 
nephroprotective activities of S.monostachyus.  
5.0 Conclusion  
The findings of this study further support the liver and 
renal protective potentials of leaf of S. monostachyus 
which can be attributed to the antioxidant properties of 
its constituents. Hence, the leaf of S. monostachyus 
posses’ hepato and nephroprotective activities against 
paracetamol- induced liver and kidney injuries. 
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